LEXINGTON, Ky.--(BUSINESS WIRE)--Life on earth evolved from simple single cell organisms into complex multi-cell life forms over billions of years by adapting to the ever-changing environment on our planet. Through all these changes, one thing has remained constant, the force of Earth’s gravity. In all living organisms, their up-down and left-right asymmetry, structural strength, size and shape of force-producing elements, sensory systems and how they age have evolved with a constant compass, 1g force.
What if we subtract that 1g force? Would cells/organisms live shorter or longer, would they become structurally stronger or weaker, would they develop more or less disease, would medications we use to treat disease have more or less effect? In the vast majority of cases the answers here are…we simply don’t know.
The 2015 ExoMed™ Conference, presented by the Exomedicine Institute, along with Space Tango, Inc., CASIS, Kentucky Space and FedEx will center on the expanding field of Exomedicine - the R&D and commercialization of medical solutions in the microgravity environment of space for applications on Earth. With the rapid advancement of micro-technologies and greatly expanded access to space, we now have an unprecedented opportunity to study and undertake novel R&D involving living organisms and disease processes in microgravity.
Join scientists, space professionals, investors and entrepreneurs for an interactive discussion about ideas, findings and experience related to microgravity research on the International Space Station (ISS). Topics will include: neurodegenerative diseases, diabetes, cancer, cystic fibrosis, regenerative medicine, etc. Click here to register.
The conference will be held on Wednesday, May 20, 2015 from 8:45am – 3:30pm at Marion Court College in Swampscott, MA. Presenters include John Barker, J.W. Goethe-Universitat; Ioana Cuzmato, Science and Technology Corporation; Twyman Clements, Space Tango; Tim Hammond, Duke University; Lynn Harper, NASA; Kelvin Hill, FedEx; Kris Kimel, Exomedicine Institute; Michael Levin, Tufts University; Mike Roberts, CASIS; and Therese White, National Health Service/U.K.